Health Facts PlusHerbs and Supplements: Vitamin C (Ascorbic acid)
Vitamin C (ascorbic acid) is a water-soluble vitamin which is necessary in the body to form collagen in bones, cartilage, muscle, and blood vessels, and aids in the absorption of iron. Dietary sources of vitamin C include fruits and vegetables, particularly citrus fruits such as oranges.
Severe deficiency of vitamin C causes scurvy. Although rare, scurvy includes potentially severe consequences, and can cause sudden death. Scurvy is treated with vitamin C, and should be under medical supervision.
Many uses for vitamin C have been proposed, but few have been conclusively demonstrated as being beneficial in scientific studies. In particular, research in asthma, cancer, and diabetes remain inconclusive, while no benefits have been found in the prevention of cataracts or heart disease.
The use of vitamin C in prevention/treatment of the common cold and respiratory infections remains controversial, with ongoing research. Forcold prevention, more than 30 clinical trials including over 10,000 participants have examined the effects of taking daily vitamin C (200mg or more). Overall, no significant reduction in the risk of developing colds has been observed. In people who developed colds while taking vitamin C, no difference in severity of symptoms has been seen overall, although a very small significant reduction in the duration of colds has been reported (approximately 10% in adults and 15% in children). Notably, a subset of studies in people living in extreme circumstances, including soldiers in sub-arctic exercises, skiers, and marathon runners, have reported a significant reduction in the risk of developing a cold of approximately 50%. This area merits additional study, and may be of particular interest to elite athletes or military personnel. Forcold treatment, numerous studies have examined the effects of starting vitamin C after the onset of cold symptoms. Overall, no significant benefits have been observed in doses up to 4 grams taken by mouth daily. Initial evidence from one study reports possible benefits with a dose of 8 grams taken at the onset of symptoms, but without additional evidence this remains indeterminate.
Antiscorbutic vitamin, ascorbate, ascorbic acid (AA), ascorbyl palmitate, calcium ascorbate, cevitamic acid, iso-ascorbic acid, sodium ascorbate.
Brand names: Vitamin C is included in thousands of multivitamin formulations. Vitamin C products in the United States include Ascorbicap, C-500-GR, Cecon, Cetane, Cevalin, Ce-Vi-Sol, Cevi-Bid,C-Gram, Ce-Vi-Sol, ll-C, Dull-C, and Flavorcee, Vita-C. Canadian products include Proflavanol C and Revitalose C-1000.
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
Causes: Scurvy is caused by a dietary deficiency of vitamin C. Although scurvy is uncommon, it may occur in malnourished individuals, those with increased vitamin C requirements (such as pregnant or breastfeeding women), or in infants receiving unsupplemented milk diets. There are rare reports of scurvy due to tolerance or resistance following long-term high-dose use, including infants born to mothers taking 400 mg/day or greater throughout their pregnancy.Symptoms: Initial symptoms of scurvy in adults may include loss of appetite, diarrhea, shortness of breath, weakness, and fever, followed by irritability, depression, leg pain, pseudoparalysis, swelling over long bones of the body, anemia, paleness, poor wound healing, corkscrew hair, dry eyes, skin thickening (hyperkeratosis), and bleeding (particularly gum bleeding, bleeding behind the eyes causing prominence [proptosis], bleeding at the joints of the ribs and sternum causing discoloration under the skin of the chest [costochondral beading, scorbutic rosary], skin bruising, or blood in the urine or stool). In infants, symptoms may include irritability, thigh tenderness, pseudoparalysis, bleeding around the lower ends of the leg bones (femur and tibia) causing pain, and assumption of a frog-leg posture. If left untreated, scurvy can proceed to seizures, shock or sudden death.History: Scurvy has been described since ancient Egypt, and epidemics were witnessed during the 16th-18th centuries, in particular among sailors. In the mid-1700''s, the British naval surgeon James Lind discovered that oranges and lemons, both sources of vitamin C, are effective in preventing/curing scurvy.Diagnosis: The diagnosis of scurvy is usually clinical, particularly in infants, based on symptoms and a history of vitamin C deficiency. Fasting blood ascorbic acid levels may be helpful, and levels below 0.10 mg/dL are considered deficient; levels of 0.10-0.19 mg/dL are considered low; levels of 0.2 mg/dL or greater are generally considered acceptable; and levels greater than 0.6 mg/dL likely rule out scurvy. White blood cell ascorbic acid concentration is considered a more accurate measurement of vitamin C nutritional status, with a level of zero suggesting scurvy; 0-7 mg/dL suggesting deficiency; 8-15 mg/dL considered low; and 15 mg/dL or greater consistent with adequate vitamin C status.Treatment: Vitamin C administered by mouth or injection is effective for curing scurvy. If vitamin C is not available, orange juice can be used for infantile scurvy. Symptoms should begin to improve within 24-48 hours, with resolution within 7 days. Treatment should be under strict medical supervision.A
Scientific studies generally suggest that vitamin C does not prevent the onset of cold symptoms when taken daily in doses of 200mg or more. However, in a subset of studies in people living in extreme circumstances, including soldiers in sub-arctic exercises, skiers, and marathon runners, significant reductions in the risk of developing colds by approximately 50% have been reported. This area merits additional study, and may be of particular interest to elite athletes or military personnel.B
Based on scientific research, vitamin C appears to improve oral absorption of iron. Concurrent vitamin C may aid in the absorption of iron dietary supplements.B
Alkaptonuria is a disorder characterized by the absence of the enzyme homogentisic acid oxidase, with a resulting accumulation of homogentisic acid in the blood and urine. Limited research reports that daily high-dose vitamin C may provide symptomatic relief and slow progression of complications of this disorder. Additional evidence is merited in this area.C
It has been suggested that low levels of vitamin C (or other antioxidants) may increase the risk of developing asthma. The use of vitamin C for asthma has been studied since the 1980s (particularly exercise-induced asthma), although the evidence in this area remains inconclusive. Additional research is necessary before a clear conclusion can be drawn.C
Dietary intake of fruits and vegetables high in vitamin C has been associated with a reduced risk of various types of cancer in population studies (particularly cancers of the mouth, esophagus, stomach, colon, or lung). However, it is not clear that it is specifically the vitamin C in these foods that is beneficial, and vitamin C supplements have not been found to be associated with this protective effect. Experts have recommended increasing dietary consumption of fruits and vegetables high in vitamin C, such as apples, asparagus, berries, broccoli, cabbage, melon (cantaloupe, honeydew, watermelon), cauliflower, citrus fruits (lemons, oranges), fortified breads/grains/cereal, kale, kiwi, potatoes, spinach, and tomatoes.C
There is not clear evidence that high-dose vitamin C by mouth or intravenous delivery is beneficial in the treatment of any type of cancer. Studies in this area have failed to demonstrate beneficial effects.C
In preliminary study, a reduced amount of calculus, visible plaque and bleeding gum sites was observed after use of vitamin C chewing gum. Further research is needed to confirm these resultsC
Prevention of premature rupture of chorioamniotic membranes (PROM)
Study results show that daily supplementation with 100mg of vitamin C after 20 weeks of gestation can effectively lessen the incidence of PROM. Please ask your Gynecologist and Pharmacist before taking any herbs or supplements.C
There are variable results of studies which have measured the association of vitamin C intake and risk of stroke. Some studies have reported no benefits of a daily dose of 700mg or more, while other research reports that daily low-dose vitamin C (45mg or more) may reduce the risk of death from stroke. Additional research is merited in this area. Individuals at risk of having a stroke should speak with their healthcare provider about the role of vitamin C supplements in stroke prevention.C
Although population research initially suggested a reduction in cataract formation among individuals taking vitamin C for at least 10 years, subsequent prospective research found no reduction in the 7-year risk of age-related cataract formation or progression with the use of daily vitamin C 500mg.D
More than 30 clinical trials including more than 10,000 participants have examined the effects of taking daily vitamin C (200mg or more) on cold prevention. Overall, no significant reduction in the risk of developing colds has been observed. In people who developed colds while taking vitamin C, no difference in severity of symptoms has been seen overall, although a very small significant reduction in the duration of colds has been reported (approximately 10% in adults and 15% in children). Laboratory experiments in which volunteers are infected with respiratory viruses while taking vitamin C have yielded differing results, but overall report small or no significant differences in symptom severity following infection.Extreme environments: Notably, a subset of studies in people living in extreme circumstances, including soldiers in sub-arctic exercises, skiers, and marathon runners, have reported a significant reduction in the risk of developing a cold of approximately 50%. This area merits additional study, and may be of particular interest to elite athletes or military personnel.D
Numerous studies have examined the effects of starting vitamin C after the onset of cold symptoms. Overall, no significant benefits have been observed in doses up to 4 grams taken by mouth daily. Initial evidence from one study reports possible benefits with a dose of 8 grams taken at the onset of symptoms, but without additional evidence this remains indeterminate. At this time, the scientific evidence does not support this use of vitamin C.D
Vitamin C does not appear to lower cholesterol levels or reduce the risk of heart attacks. Effects on cholesterol plaques in heart arteries (atherosclerosis) remain unclear, and some studies suggest possible beneficial vasodilation (artery opening) properties. Based on the current scientific evidence, vitamin C is generally not recommended for this use. People at risk of heart attacks should speak with their healthcare provider to consider preventive measures such as aspirin.D
In a randomized controlled trial, no significant benefits or harmful effects were associated with ascorbic acid supplementation throughout the first 28 days of life.D
A: Strong scientific evidence for this use;
B: Good scientific evidence for this use;
C: Unclear scientific evidence for this use;
D: Fair scientific evidence against this use;
F: Strong scientific evidence against this use.
Uses based on tradition or theory
The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
Acne, Alzheimer''s disease, anemia, anemia in hemodialysis patients, antiviral, antioxidant, atherosclerosis, attention deficit hyperactivity disorder, autism, bronchitis, capillary fragility, cervical dysplasia, Chediak-Higaski syndrome, constipation, cystic fibrosis, delayed onset muscle soreness, dental cavities, dermatitis, diabetes, eye disorders, fluorosis, furunculosis, gallbladder disease, gastric ulcer, hay fever,Helicobacter pyloriinfection, high blood pressure, high cholesterol, histamine detoxification, idiopathic thrombocytopenic purpura, immune stimulation, infertility, jellyfish stings, lead toxicity, male infertility, macular degeneration, melasma, menorrhagia, nitroglycerin activity prolongation (nitrate tolerance prevention), oligoasthenozoospermia, osteoporosis, pneumonia prevention, pressure sores, preterm labor, reduction of levodopa side effects, reflex sympathetic dystrophy, skin sun damage, stomach ulcers, sunburn prevention, tuberculosis, urinary acidification, vaginitis, wound healing.
The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.
Dosage forms: Vitamin C is available in multiple dosage forms including oral (regular or sustained release) and intravenous delivery. Oral forms include 100-1000mg capsules or tablets, powders, liquids/oral solutions (for example, 1-4g/5mL).
Food sources: Apples, asparagus, berries, broccoli, cabbage, melon (cantaloupe, honeydew, watermelon), cauliflower, citrus fruits (lemons, oranges), fortified breads/grains/cereal, kale, kiwi, potatoes, spinach, tomatoes.
Dietary Reference Intakes (DRIs): Recommended daily intake by the U.S. Food and Nutrition Board of the institute of Medicine for men older than 18-years-old is 90 mg/day; for women older than 18-years-old is 75 mg/day; for pregnant women older than 18-years-old is 85 mg/day; for breastfeeding women older than 18-years-old is 120 mg/day. Recently, some experts have questioned whether the recommended daily intake should be raised. Others have recommended higher intake in some individuals, such as smokers, in whom an additional 35 mg/day has been recommended by some.
Upper limit of intake (UL): Should not exceed 2000 mg/day in men or women older than 18-years-old (including pregnant or breastfeeding women).
Scurvy/deficiency: Vitamin C administered by mouth or injection is effective for curing scurvy. In adults, 100-250 mg by mouth four times daily for 1 week is generally sufficient to improve symptoms and replete body vitamin C stores. Some experts have recommended 1-2 grams/day for 2 days followed by 500 mg/day for 1 week. Symptoms should begin to improve within 24-48 hours, with resolution within 7 days. Treatment should be under strict medical supervision. For asymptomatic vitamin C deficiency, lower daily doses may be used.
Plaque/calculus on teeth: Patients chewed five or 10 pieces of gum containing 60 mg of vitamin C per day for a period of 3 months in one study.
Prevention of premature rupture of chorioamniotic membranes: 100 mg of vitamin C per day has been studied.
Common cold prevention/treatment: For cold prevention, 200 mg/day or higher has been used. For cold treatment, up to 1000-2000 mg/day has been used.
Other: Dosing regimens of vitamin C with unproven effectiveness or safety include: 120-450 mg/day for antioxidant effects; 500-2000 mg prior to exercise for exercise-induced asthma prevention; 45-1000 mg/day for atherosclerosis prevention; 3000 mg/day for delayed-onset muscle soreness; 1000-2000 mg/day for diabetes; 50 mg/day for gastric ulcer; 300-3000 mg/day for high cholesterol; 200 mg/day for male infertility; 2000 mg/day for sunburn protection; 3-12 grams/day for urine acidification; 1000-1500 mg/day for wound healing.
Adequate Intakes (AIs) and U.S. Dietary Reference Intakes (DRIs): The AI for infants ages 0-6 months-old is 40 mg/day, and for infants 7-12 months-old is 50 mg/day. The DRI for children 1-3 years-old is 15 mg/day; for 4-8 years-old is 25 mg/day; for 9-13 years-old is 45 mg/day; for 14-18 year-old males is 75 mg/day; for 14-18 year-old females is 65 mg/day; for 14-18 year-old pregnant females is 80 mg/day; for 14-18 year-old breastfeeding females is 115 mg/day. Recently, some experts have questioned whether recommended daily intakes should be raised.
Tolerable Upper Intake Levels (UL): The UL has not been determined for infants ages 0-12 months, and vitamin C in this group should only be derived from food intake to avoid excess doses. The UL for children ages 1-3 years-old is 400 mg/day; the UL for ages 4-8 years-old is 650 mg/day; the UL for ages 9-13 years-old is 1200 mg/day; the UL for ages 14-18 years-old is 1800 mg/day (including pregnant or breastfeeding females).
Scurvy/deficiency: In children, 100-300 mg/day by mouth in divided doses for 2 weeks has been used. Older or larger children may require doses closer to adult recommendations. If vitamin C is not available, orange juice may be used for infantile scurvy. Symptoms should begin to improve within 24-48 hours, with resolution within 7 days. Treatment should be under strict medical supervision. For asymptomatic vitamin C deficiency, lower daily doses may be used.
The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.
General: Vitamin C is generally regarded as safe in amounts obtained from foods. Vitamin C supplements are also generally regarded as safe in most individuals in recommended amounts, although side effects are rarely reported including nausea, vomiting, heartburn, abdominal cramps, and headache. Dental erosion may occur from chronically chewing vitamin C tablets.
High doses/toxicity: High doses of vitamin C have been associated with multiple adverse effects, particularly at doses greater than 2000 mg/day. These include kidney stones, severe diarrhea, nausea, and gastritis. Rarely, flushing, faintness, dizziness, and fatigue have been noted. Large doses may precipitate hemolysis (red blood cell destruction) in patients with glucose 6-phosphate dehydrogenase deficiency. High doses of vitamin C should be avoided in people with conditions aggravated by acid loading, such as cirrhosis, gout, renal tubular acidosis, or paroxysmal nocturnal hemoglobinuria. Parenteral (injected) vitamin C may cause dizziness, faintness, injection site discomfort, and in high doses may lead to renal insufficiency (kidney function problems). In cases of toxicity due to massive ingestions of vitamin C, forced fluids and diuresis may be beneficial.
Warnings: High doses of vitamin C should be avoided in patients with glucose 6-phosphate dehydrogenase deficiency, kidney stones, cirrhosis, gout, renal tubular acidosis, or paroxysmal nocturnal hemoglobinuria.
Tolerance/resistance: Healthy adults who take chronic large doses of vitamin C may experience low blood levels of vitamin C when they stop taking the high doses and resume normal intake. To avoid this potential complication, people who are taking high doses who wish to reduce their intake should do so gradually rather than acutely. There are rare reports of scurvy due to tolerance or resistance following cessation after long-term high-dose use, such as in infants born to mothers taking 400 mg/day or greater throughout their pregnancy.
Pregnancy: Vitamin C intake from food is generally considered safe during pregnancy. However, it is not clear if vitamin C supplementation in amounts exceeding Dietary Reference Intake recommendations is safe or beneficial. There are rare reports of scurvy due to tolerance/resistance in infants born to mothers taking 400 mg/day or greater throughout their pregnancy.
Breastfeeding: Vitamin C is present in breastmilk. Vitamin C intake from food is generally considered safe in breastfeeding mothers. Limited research suggests that vitamin C in breastmilk may reduce the risk of the development of childhood allergies. It is not clear if vitamin C supplementation in amounts exceeding Dietary Reference Intake recommendations is safe or beneficial.
Most herbs and supplements have not been thoroughly tested for interactions with other herbs, supplements, drugs, or foods. The interactions listed below are based on reports in scientific publications, laboratory experiments, or traditional use. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy.
Acetaminophen (Tylenol): Vitamin C may increase adverse effects associated with acetaminophen.
Antacids: Vitamin C may increase adverse effects associated with aluminum-containing antacids such as aluminum hydroxide (Maalox, Gaviscon).
Aspirin: Vitamin C may increase blood levels and adverse effects of aspirin, whereas aspirin may decrease blood levels of vitamin C.
Barbiturates: The effects of vitamin C may be decreased by barbiturates including phenobarbital (Luminal, Donnatal), pentobarbital (Nembutal), or secobarbital (Seconal).
Fluphenazine (Permitil, Prolixin): Vitamin C supplementation may decrease levels of the drug fluphenazine in the body.
HIV medications (protease inhibitors): Concomitant administration of high doses of vitamin C can reduce steady-state indinavir plasma concentrations.
Levodopa (Dopar, Larodopa): There is limited case report evidence that high dose vitamin C may reduce side effects of levodopa therapy such as nausea or malcoordination.
Nicotine: Nicotine products such as cigarettes, cigars, chewing tobacco, or nicotine patches may decrease the effects of vitamin C.
Oral contraceptives/estrogens: Oral estrogens may decrease the effects of vitamin C in the body. When taken together, vitamin C may increase blood levels of ethinyl estradiol.
Tetracyclines: The effects of vitamin C may be decreased by tetracycline antibiotics such as doxycycline (Vibramycin), minocycline (Minocin), or tetracycline (Sumycin).
Warfarin (Coumadin): Vitamin C in high doses appears to interfere with the blood thinning effects of warfarin by lowering prothrombin time (PT), as noted in case reports in the 1970s. Complications have not been reported (such as increased blood clots).
Interactions with Herbs and Dietary Supplements
Iron: When taken together, vitamin C may increase the absorption of iron in the gastrointestinal tract, although this effect appears to be variable and may not be clinically significant.
Lutein: Vitamin C may increase absorption of lutein vitamin supplements.
Vitamin B12 (cobalamin, cyanocobalamin): Large doses of vitamin C may interfere with the absorption and metabolism of vitamin B12.
Bilirubin: Vitamin C supplements may cause false increases in tests of blood bilirubin levels.
Carbamazepine levels: Vitamin C supplements may cause false increases in blood carbamazepine levels.
Creatinine: Vitamin C supplements may cause false increases in blood creatinine levels.
Glucose: Vitamin C supplements may interfere with the accuracy of blood glucose tests.
LDH (lactose dehydrogenase): Vitamin C may cause a false decrease in blood LDH levels.
Prothrombin time (PT): Vitamin C in high doses appears to interfere with the blood thinning effects of warfarin by lowering prothrombin time (PT), as noted in case reports in the 1970s. Complications have not been reported (such as increased blood clots).
SGOT (glutamic oxaloacetic transaminase): Vitamin C supplements may cause false increases in blood SGOT levels.
Stool occult blood (guaiac): Vitamin C supplements can cause false-negative stool occult blood tests, within 48-72 hours after vitamin C ingestion.
Theophylline levels: Vitamin C supplements may cause false decreases in blood theophylline levels.
Uric acid levels: Vitamin C supplements may cause false increases in blood uric acid levels.
Urinary acetaminophen (Tylenol): Vitamin C supplements can cause false-negative urine acetaminophen tests.
Urinary glucose: Vitamin C supplements can cause false-positive urinary glucose results with the cupric sulfate reagent test and false-negative urinary glucose results with the glucose oxidase test, within 48-72 hours after vitamin C ingestion.
This information is based on a systematic review edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).
Abudu N, Miller JJ, Attaelmannan M, et al. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin Chim Acta 2004;339(1-2):11-25.
Akikusa JD, Garrick D, Nash MC: Scurvy: forgotten but not gone. J Paediatr Child Health 2003 Jan-Feb; 39(1): 75-7
Anonymous. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. Arch Ophthalmol 2001; 119:1439-1452.
Auer BL, Auer D & Rodgers AL: Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998; 28(9):695-700.
Aukerman D. Do vitamin C supplements reduce cardiovascular disease mortality? Am Fam Physician 2004;69(7):1723-1724.
Balcke P, Schmidt P, Zazgornik J et al: Ascorbic acid aggravates secondary hyperoxalemia in patients in chronic hemodialysis. Ann Intern Med 1984; 101:344-345.
Ballin, A, Brown, EJ, Koren, G, et al. Vitamin C-induced erythrocyte damage in premature infants. J Pediatr 1988; 113(1 Pt 1):114.
Bass WT, Malati N, Castle MC et al: Evidence for the safety of ascorbic acid administration to the premature infant. Am J Perinatol 1998; 15:133-140.
Basu TK: Vitamin C-aspirin interactions. Int J Vitam Nutr Res Suppl 1982; 23:83-90.
Beitz R, Mensink GB, Fischer B. Blood pressure and vitamin C and fruit and vegetable intake. Ann Nutr Metab 2003;47(5):214-220.
Bendich A, Langseth L: The health effects of vitamin C supplementation: a review. J Am Coll Nutr 1995; 14:124-136.
Berenson JR, Swift RA, Ferretti D, et al. A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma. Clin Lymphoma 2004;5(2):130-134.
Buttery JE, Boord S, Ludvigsen H. Ascorbate interference in the urinary screen for acetaminophen. Clin Chem 1988; 34:769.
Campbell GD, Steinberg MH, Bower JD. Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med 1975; 82:810.
Casanueva E, Ripoll C, Meza-Camacho C, et al. Possible interplay between vitamin C deficiency and prolactin in pregnant women with premature rupture of membranes: facts and hypothesis. Med Hypotheses 2005;64(2):241-247.
Casanueva E, Ripoll C, Tolentino M, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr 2005;81(4):859-863.
Castello T, Girona L, Gomez MR, et al: The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord 1996; 34:592-593.
Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999; 354(9181):810-816.
Charlton KE, Rabinowitz TL, Geffen LN, et al. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J Nutr Health Aging 2004;8(2):99-107.
Chen WT, Yan HC, Yu FC. Vitamin C improves vascular resistance in patients with chronic renal failure. Kidney Int 2003;64(6):2325-2326.
Cohen HA, Neuman I, Nahum H. Blocking effect of vitamin C in exercise-induced asthma. Arch Pediatr Adolesc Med 1997; 151:367-370.
Collins N. Adding vitamin C to the wound management mix. Adv Skin Wound Care 2004;17(3):109-112.
Conte D, Brunelli L, Ferrario L, et al. Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis. Acta Haematol 1984; 72:117-120.
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 1996; 155:1847-1851.
Daniel TA, Nawarskas J: Vitamin C in the prevention of nitrate tolerance. Ann Pharmacother 2000; 34:1193-1197.
Darlow BA, Buss H, McGill F, et al. Vitamin C supplementation in very preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2005;90(2):F117-F122.
Deicher R, Ziai F, Habicht A, et al. Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant 2004;19(9):2319-2324.
Dolske MC, Spollen J, McKay S, et al. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:765-774.
Domingo JL, Gomez M, Llobet JM, et al. Effect of ascorbic acid on gastrointestinal aluminum absorption. Lancet 1991; 338:1467.
Douglas R, Hemila H, D''Souza R, et al. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2004;(4):CD000980.
Doyle J, Verman HJ, Stevenson DK, et al. Does vitamin C cause hemolysis in premature newborn infants? Results of a multicenter double-blind, randomized, controlled trial. J Pediatr 1997; 130:103-109.
Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid (letter). Lancet 1999; 354(9195):2048-2049.
Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002;287(24):3223-3229.
Fang JC, Kinlay S, Beltrame J et al: Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002; 359:1108-1013.
Feldman EB, Gold S, Greene J et al: Ascorbic acid supplements and blood pressure: a four-week pilot study. Ann N Y Acad Sci 1992; 342-344.
Finley EB & Cerklewski FL: Influence of ascorbic acid supplementation on copper status in young adult men. Am J Clin Nutr 1983; 37:553-556.
Fitzpatrick RE & Rostan EF: Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 2002; 38(3):231-236.
Fotherby MD, Williams JC, Forster LA et al: Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 2000; 18(4):411-415.
Ghosh SK, Ekpo EB, Shah IU et al: A double-blind placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 1994; 40:268-272.
Giunta, JL. Dental erosion resulting from chewable vitamin C tablets. J Am Dent Assoc 1983; 107:253.
Gokce N, Keaney JF Jr, Frei B et al: Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999; 99:3234-3240.
Golde DW. Vitamin C in cancer. Integr Cancer Ther 2003;2(2):158-159.
Grebe G, Martinez-Torres C & Layrisse M: Effect of meals and ascorbic acid on the absorption of a therapeutic dose of iron on ferrous and ferric salts. Curr Ther Res 1975; 17:382-397.
Guan W, Osanai T, Kamada T et al: Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn Circ J 1999; 63:924-928.
Halberstein RA, Abrahmsohn GM. Clinical management and control of alveolalgia ("dry socket") with vitamin C. Am J Dent 2003;16(3):152-154.
Halperin EC, Gaspar L, George S et al: A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. Int J Radiat Oncol Biol Phys 1993; 26:413-416.
Hampl JS, Taylor CA, Johnston CS. Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 2004;94(5):870-875.
Hansten PD & Hayton WL: Effect of antacid and ascorbic acid on serum salicylate concentration. J Clin Pharmacol 1980; 20:326-331.
Haslam RHA, Balby JT & Rademaker AW: Effects of megavitamin therapy on children with attention deficit disorders. Pediatrics 1984; 74:103-111.
Hemila H. Vitamin C supplementation and respiratory infections: a systematic review. Mil Med 2004;169(11):920-925.
Herbert V & Jacob E: Destruction of vitamin B12 by ascorbic acid. JAMA 1974; 230:241-242.
Hirashima O, Hiroaki K, Motoyama T et al: Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol 2000; 35(7):1860-1866.
Hoppu U, Rinne M, Salo-Vaananen P, et al. Vitamin C in breast milk may reduce the risk of atopy in the infant. Eur J Clin Nutr 2005;59(1):123-128.
Hoyt CJ: Diarrhea from vitamin C. JAMA 1980; 244:1674.
Huh CH, Seo KI, Park JY, et al. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology 2003;206(4):316-320.
Hume R, Johnstone JM & Weyers E: Interaction of ascorbic acid and warfarin. JAMA 1972; 219:1479.
Hunter DJ, Manson JE, Colditz GA et al: A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 1993; 329:234-240.
Hussain MAM, Flynn DM, Green N et al: Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet 1977; 1:977-979.
Ihara H, Shino Y, Hashizume N. Recommended dietary allowance for vitamin C in the United States is also applicable to a population of young Japanese women. J Clin Lab Anal 2004;18(6):305-308.
Iwamoto N, Nakakuma H, Ota N et al: Ascorbic acid-induced hemolysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Am J Hematol 1994; 47:337-338.
Jacobs EJ, Connell CJ, McCullough ML et al: Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort. Cancer Epidemiol Biomarkers Prev 2002; 11:35-41.
Jaffe RM, Kasten B, Young DS et al: False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975; 83:824-826.
Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E et al: Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998; 7:449-454.
Johnston CS, Dancho CL, Strong GM. Orange juice ingestion and supplemental vitamin C are equally effective at reducing plasma lipid peroxidation in healthy adult women. J Am Coll Nutr 2003;22(6):519-523.
Johnston CS, Retrum KR & Srilakshmi JC: Antihistamine effects and complications of supplemental vitamin C. J Am Diet Assoc 1992; 92:988-989.
Kapil U, Singh P, Bahadur S, et al. Association of vitamin A, vitamin C and zinc with laryngeal cancer. Indian J Cancer 2003;40(2):67-70.
Keven K, Kutlay S, Nergizoglu G, et al. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis 2003;41(6):1233-1239.
Kim JY, Lee SM. Effect of ascorbic acid on hepatic vasoregulatory gene expression during polymicrobial sepsis. Life Sci 2004;75(16):2015-2026.
Kim MK, Sasaki S, Sasazuki S, et al. Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects. Br J Nutr 2004;91(1):81-90.
Knodell RG, Tate MA, Akl BF et al: Vitamin C prophylaxis for posttransfusion hepatitis: lack of effect in a controlled trial. Am J Clin Nutr 1981; 34:20-23.
Kongerud J, Crissman K, Hatch G, et al. Ascorbic acid is decreased in induced sputum of mild asthmatics. Inhal Toxicol 2003;15(2):101-109.
Krasner N, Moore MR, Dow J et al: Ascorbic acid and ethanol metabolism. Lancet 1974; 21:693-695.
Kushi LH, Folsom AR, Prineas RJ et al: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334:1156-62.
Lagiou P, Samoli E, Lagiou A, et al. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 2004;15(1):67-72.
Lawton JM, Conway LT, Crosson JT et al: Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 1985; 45:950-951.
Lee DH, Folsom AR, Harnack L, et al. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr 2004;80(5):1194-1200.
Lee KW, Lee HJ, Kang KS et al: Preventive effects of vitamin C on carcinogenesis. Lancet 2002; 359:172.
Levine GN, Frei B, Koulouris SN et al: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93:1107-1113.
Levy R, Shriker O, Porath A et al: Vitamin C for the treatment of recurrent furunculosis in patients with impaired neutrophil functions. J Infect Dis 1996; 173:1502-1505.
Lingstrom P, Fure S, Dinitzen B, et al. The release of vitamin C from chewing gum and its effects on supragingival calculus formation. Eur J Oral Sci 2005;113(1):20-27.
Loh HS, Watters K & Wilson CW: The effects of aspirin on the metabolic availability of ascorbic acid in human beings. J Clin Pharmacol 1973; 13:480-486.
Lynch SR: Ascorbic acid and iron nutrition. NY State J Med 1981; 81:1132-1133.
Masaki KH, Losonczy KG, Izmirlian G et al: Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54(2):1265-1272.
McAllister CJ, Scowder EB, Dewberry FL et al: Renal failure secondary to massive infusion of vitamin C. JAMA 1984; 252:1684.
McLeod DC, Nahata MC: Inefficacy of ascorbic acid as a urinary acidifier. N Engl J Med 1977; 296:1413.
Mitch WE, Johnson MW, Kirshenbaum JM et al: Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther 1981; 29:318-321.
Moertel CG, Fleming TR, Creagen ET et al: High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med 1985; 312:137-141.
Mohsenin V, Dubois AB & Douglas JS: Effect of ascorbic acid on response to methacholine challenge in asthmatic subjects. Am Rev Respir Dis 1983; 127:143-147.
Morris JC, Beeley L & Ballantine N: Interaction of ethinyl estradiol with ascorbic acid in man. Br Med J 1981; 283:503.
Mullan BA, Young IS, Fee H et al: Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002; 40:804-809.
Nahata MC, Shring L & Lampman T: Effect of ascorbic acid on urine pH in man. Am J Hosp Pharm 1977; 34:1234-1237.
Nakamoto Y, Motohashi S, Kasahara H et al: Irreversible tubulointerstitial nephropathy associated with prolonged, massive intake of vitamin C. Nephrol Dial Transplant 1998; 13:754-756.
Nam CM, Oh KW, Lee KH, et al. Vitamin C intake and risk of ischemic heart disease in a population with a high prevalence of smoking. J Am Coll Nutr 2003;22(5):372-378.
Nathens AB, Neff MJ, Jurkovich GJ et al: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236(6):814-822.
Nienhuis AW, Delea C, Aamodt R et al: Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload. In: Birth Defects: Original Article Series 1976; 12:177-185.
Nightingale AK, Schmitt M, Frenneaux MP. Vitamin C in heart failure: hype or hope? Hypertension 2004;43(2):e5-e6.
Nyyssonen K, Parviainen MT, Salonen R et al: Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. Br Med J 1997; 314:634-638.
O''Brien RT: Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major. Ann N Y Acad Sci 1974; 232:221-225.
O''Malley PG. Review: vitamin E, vitamin C, and possibly coenzyme Q10 are ineffective for preventing or treating cardiovascular disease. ACP J Club 2004;140(3):73.
Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004;140(7):533-537.
Paleologos M, Cumming RG & Lazarus R: Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998; 148(1):45-50.
Petersen EE, Magnani P. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2004;117(1):70-75.
Piccirillo G, Nocco M, Moise A, et al. Response: Vitamin C in Heart Failure: Hope! Hypertension 2004;
Pradeep JK, Kehinde EO & Daar AS: Symptomatic response to ascorbic acid. Br J Urol 1996; 77:319-320.
Pru, C, Eaton, J, Kjellstrand, C. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 1985; 39:112.
Raitakari OT, Adams MR, McCredie RJ et al: Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 2000; 35(6):1616-1621.
Ram FS, Rowe BH, Kaur B. Vitamin C supplementation for asthma. Cochrane Database Syst Rev 2004;(3):CD000993.
Ramenghi U, Saracco P, Timeus F et al: Use of ascorbate for the treatment of refractory idiopathic thrombocytopenic purpura in children. Am J Pediatr Hematol Oncol 1991; 13:486-489.
Rees DC, Kelsey H & Richards JDM: Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. Br Med J 1993; 306:841-842.
Riordan HD, Riordan NH, Jackson JA, et al. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J 2004;23(2):115-118.
Rolf C, Cooper TG, Yeung CH et al: Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized placebo-controlled, double-blind study. Hum Reprod 1999; 14(4):1028-1033.
Romney SL, Duttagupta C, Basu J et al: Plasma vitamin C and uterine cervical dysplasia. Am J Obstet Gynecol 1985; 151:976-980.
Rosenthal G: Interaction of ascorbic acid and warfarin. JAMA 1971; 215:1671.
Rossig L, Hoffmann J, Hugel B et al: Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001; 104:2182-2187.
Rotblatt MD, Koda-Kimble MA: Review of drug interference with urine glucose tests. Diabetes Care 1987; 10:103-110.
Rowbotham B, Roeser HP: Iron overload associated with congenital pyruvate kinase deficiency and high dose ascorbic acid ingestion. Aust N Z J Med 1984; 14:687-669.
Sacks W, Simpson GM: Ascorbic acid in levodopa therapy. Lancet 1975; 1:527.
Saitoh H, Komiyama A, Norose N et al: Development of the accelerated phase during ascorbic acid therapy in Chediak-Higashi: syndrome and efficacy of colchicine on its management. Br J Hematol 1981; 48:79-84.
Sardi B. High-dose vitamin C and iron overload. Ann Intern Med 2004;140(10):846-847.
Schectman G: Estimating ascorbic acid requirements for cigarette smokers. Ann N Y Acad Sci 1993; 686:335-346.
Schnitzler CM, Schnaid E, Macphail AP, et al. Ascorbic Acid Deficiency, Iron Overload and Alcohol Abuse Underlie the Severe Osteoporosis in Black African Patients with Hip Fractures - A Bone Histomorphometric Study. Calcif Tissue Int 2004;
Schorah CJ, Tormey WP, Brooks GH et al: The effect of vitamin C supplement on body weight, serum proteins, and general health of an elderly population. Am J Clin Nutr 1981; 34:871-876.
Schulz HU, Schurer M, Krupp S, et al. Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine--a double-blind study in healthy subjects. Int J Clin Pharmacol Ther 2004;42(9):481-487.
Sestili MA: Possible adverse health effects of vitamin C and ascorbic acid. Semin Oncol 1983; 10:299-304.
Sezer S, Ozdemir FN, Yakupoglu U et al: Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs 2002; 26(4):366-370.
Shaud MA & Cohen RJ: Effect of aspirin ingestion on ascorbic acid levels in rheumatoid arthritis. Lancet 1971; 1:937-938.
Sketris IS, Farmer PS & Fraser A: Effect of vitamin C on the excretion of methotrexate. Cancer Treat Rep 1984; 68:446-447.
Slain D, Amsden JR, Khakoo RA, et al. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. Pharmacotherapy 2005;25(2):165-170.
Smith EC, Skalski RJ, Johnson GC et al: Interaction of ascorbic acid and warfarin. JAMA 1972; 221:1166.
Sneed SM, Zane C & Thomas R: The effects of ascorbic acid, vitamin B6, vitamin B12, and folic acid supplementaton on the breast milk and maternal nutritional status of low socioeconomic lactating women. Am J Clin Nutr 1981; 34:1338-1346.
Solzbach U, Hornig B, Jeserich M et al: Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997; 96:1513-1519.
Souney PF, Steele L & Polk F: Effect of vitamin B complex and ascorbic acid on the antimicrobial activity of cefazolin sodium. Am J Hosp Pharm 1982; 39:840-841.
Soutar A, Seaton A & Brown K: Bronchial reactivity and dietary antioxidants. Thorax 1997; 52:166-170.
Spector SL: Use of provocation techniques for the evaluation of drug efficacy. J Allergy Clin Immunol 1979; 64:677-684.
Stantic-Pavlinic M, Banic S, Marin J, et al. Vitamin C--a challenge in management of rabies. Swiss Med Wkly 2004;134(21-22):326-327.
Steyn PS, Odendaal HJ, Schoeman J, et al. A randomised, double-blind placebo-controlled trial of ascorbic acid supplementation for the prevention of preterm labour. J Obstet Gynaecol 2003;23(2):150-155.
Straw GM, Bigelow LB & Kirch DG: Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid. J Clin Psychopharmacol 1989; 9:130-132.
Sullivan JF & Eissenstein AB: Ascorbic acid depletion during hemodialysis. JAMA 1972; 220:1697.
Susick RL Jr & Zannoni VG: Effect of ascorbic acid on the consequences of acute alcohol consumption in humans. Clin Pharmacol Ther 1987; 41:502-509.
Swartz RD, Wesley JR, Somermeyer MG et al: Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med 1984; 100:530.
Taji Y, Morimoto T, Okada K, et al. Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients. J Nephrol 2004;17(4):537-543.
Tanaka H, Matsuda T, Miyagantani Y et al: Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized prospective study. Arch Surg 2000; 135:326-331.
Tanumihardjo SA, Li J, Dosti MP. Lutein absorption is facilitated with cosupplementation of ascorbic acid in young adults. J Am Diet Assoc 2005;105(1):114-118.
Taper HS, Jamison JM, Gilloteaux J, et al. Inhibition of the development of metastases by dietary vitamin C:K3 combination. Life Sci 2004;75(8):955-967.
Tarng D-C, Huang T-P: A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload. Nephrol Dial Transplant 1998; 13:2867-2872.
Taylor A, Jacques PF, Chylack LT Jr et al: Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr 2002; 75(3):540-549.
Temple RJ. Vitamin C hypertension. Am J Ther 2003;10(3):234-235.
ter Riet G, Kessels AG & Knipschild PG: Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers. J Clin Epidemiol 1995; 48:1453-1460.
Teramoto K, Daimon M, Hasegawa R, et al. Acute effect of oral vitamin C on coronary circulation in young healthy smokers. Am Heart J 2004;148(2):300-305.
Tielens JAE: Vitamin C for paroxetine- and fluvoxamine-associated bleeding. Am J Psychiatry 1997; 154:883-884.
Ting S, Mansfield LE & Yarbrough J: Effects of ascorbic acid on pulmonary functions in mild asthma. J Asthma 1983; 20:39-42.
Tomoda H, Yoshitake M, Morimoto K et al: Possible prevention of postangioplasty restenosis by ascorbic acid. Am J Cardiol 1996; 78:1284-1286.
Tousoulis D, Antoniades C, Tountas C, et al. Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease. Diabetes Care 2003;26(10):2749-2753.
Traikovich SS: Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg 1999; 125(10):1091-1098.
Traxer O, Huet B, Poindexter J, et al. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 2003;170(2 Pt 1):397-401.
Tsujikawa T, Kanauchi O, Andoh A, et al. Supplement of a chitosan and ascorbic acid mixture for Crohn''s disease: a pilot study. Nutrition 2003;19(2):137-139.
Ural AU: Anemia related to ascorbic acid deficiency. Am J Hematol 1997; 56:69.
Van Steirteghem AC, Robertson EA & Young DS: Influence of large doses of ascorbic acid on laboratory test results. Clin Chem 1978; 24:54-57.
Wandzilak TR, D''Andre SD, Davis PA et al: Effect of high dose vitamin C on urinary oxalate levels. J Urol 1994; 151:834-837.
Watanabe H, Kakihana M, Ohtsuka S et al: Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. Circulation 1998; 97:886-891.
Watanabe H, Kakihana M, Ohtsuka S et al: Randomized, double-blind, placebo-controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance. J Am Coll Cardiol 1998; 31:1323-1329.
Winklhofer-Roob BM, Ellemunter H, Fruhwirth M et al: Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation. Am J Clin Nutr 1997; 65:1858-1866.
Wong K, Thomson C, Bailey RR et al: Acute oxalate nephropathy after a massive intravenous dose of vitamin C (letter). Aust N Z J Med 1994; 24:410-411.
Zhang C, Williams MA, Frederick IO, et al. Vitamin C and the risk of gestational diabetes mellitus: a case-control study. J Reprod Med 2004;49(4):257-266.
Zollinger PE, Tuinebreijer WE, Kreis RW et al: Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial. Lancet 1999; 354(9195):2025-2028.
. The information provided should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. Talk to your health care provider before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Copyright 2005 . All Rights Reserved.
Other ResourcesCopyright Privacy Accessibility Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health Department of Health & Human Services